Editors

Editor (Adis International Limited, Auckland, New Zealand):

Sue Pochon

Section Editors (Adis International Limited, Auckland, New Zealand):

Martin Chopra

Alison Fitches

Kathy Fraser

Rod McNab

Kate Palmer

Dene Peters

Amitabh Prakash

David Williamson

Editors Emeriti:

Professor Anthony W. Fox, MSc MBBS MD FFPM FRCP DipPharmMed MCSFS DipFHI MFMLM CBiol. King's College London, London, England

Dr Shaun Kilminster, BSc(Hon) PGCEd MSc(Psych) CPsychol PhD FSS Hon FFPM. Institute of Naval Medicine, Alverstoke, England

Dr Robert N. Smith, BSc MD FRCP FFPM. St Ippolytis, Hitchin, England

Dr Noel Snell, FRCP FFPM FRIPH FIBiol. National Heart & Lung Institute, London, England

Editorial board members:

Dr Peter R. Arlett, MD MRCP. European Medicines Agency, Amsterdam, the Netherlands

Dr John F. Beary III, MD FACP. University of Cincinnati, Cincinnati, OH, USA

Dr Sander Becker, MD. Consultants in Pharmaceutical Medicine, Rose Bay North, NSW, Australia

Dr Ambrogio Bottoni, MD. Pfizer Inc., Milan, Italy

Dr Torbjӧrn Callréus, MD PhD. Malta Medicines Authority, San Ġwann, Malta

Dr Norbert Clemens, MD PhD CPI. Association of Clinical Research Professionals Academy Board of Trustees, Heidelberg, Germany

Mr Francis P. Crawley, PhL. Good Clinical Practice Alliance – Europe, Brussels, Belgium

Dr Jean-Paul Deslypere, MD PhD. Council on Education in Pharmaceutical Medicine, Singapore

Dr Francesco De Tomasi, MD. Italian Society of Pharmaceutical Medicine, Milan, Italy

Professor Stephen J.W. Evans, BA MSc FRCP FISPE Hon. FRCP. London School of Hygiene and Tropical Medicine, London, England

Dr Georg Ferber, PhD. Statistik Georg Ferber GmbH, Riehen, Switzerland

Professor Sanjay K. Garg, PhD. University of South Australia, Adelaide, SA, Australia

Dr E. Stewart Geary, MD. Eisai Co. Ltd., Tokyo, Japan

Mr Kenneth A. Getz, MBA. Tufts University Medical School, Boston, MA, USA

Mr Ari Gnanasakthy, BSc MSc MBA. RTI Health Solutions, Research Triangle Park, NC, USA

Dr Ulrich Granzer, PhD. Granzer Regulatory Consulting & Services, Munich, Germany

Professor Jan D. Hirsch, BSPharm PhD. University of California, Irvine, CA, USA

Mr Alan Hunter, LLB BPharm, FPS, FTOPRA. Independent Pharmaco-Legal Adviser, Staines, England

Dr Ambrose O. Isah, MD. University of Benin, Benin, Nigeria, Africa

Dr Greg Koski, MD PhD CPI. Alliance for Clinical Research Excellence and Safety, Cambridge, MA, USA

Dr Marlene Llopíz Avíles, BA MD MPH. Association of Medical Specialists in the Pharmaceutical Industry, Mexico City, Mexico

Dr Marcelo Marotti, MD PhD. AstraZeneca UK Ltd., Macclesfield, England

Dr Peter G. M. Mol, PhD, PharmD. Dutch Medicines Evaluation Board, Utrecht, the Netherlands

Dr Shunsuke Ono, PhD. University of Tokyo, Tokyo, Japan

Professor Sir Michael Rawlins, BSc MD FRCP FFPM. Medicines and Healthcare Products Regulatory Agency, London, England

Dr Klaus Rose, MD MS. Klausrose Consulting, Riehen, Switzerland

Professor Sam Salek, BPharm PhD RPh MRPSGB FFPM FESCP. University of Hertfordshire, Hatfield, England

Professor Grannum R. Sant, MD FRCS FACS. Tufts University School of Medicine, Boston, MA, USA

Dr Ruth Savage, MB BS MSc. University of Otago, Dunedin, New Zealand

Dr Johanna A. Schenk, MD FFPM DipPharmMed DGPharMed. PPH plus GmbH & Co. KG, Hochhein/Main, Germany

Dr Jeffrey W. Sherman, MD FACP. Horizon Pharma, Deerfield, IL, USA

Dr Honorio Silva, MD. International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine, New York, NY, USA

Dr Almath Spooner, PhD. Health Products Regulatory Agency, Dublin, Ireland

Professor Peter D. Stonier, BA BSc PhD MB ChB MRCPsych FRCP FRCPE FFPM. King’s College London, London, England

Dr Robert Temple, MD. Center for Drug Evaluation & Research, Food and Drug Administration, Rockville, MD, USA

Professor Rolf Teschke, MD. Klinikum Hanau, Hanau, Germany

Professor Stuart R. Walker, BSc PhD CChem CBiol FRSC FIBiol FInstD FRCPath. Centre for Innovation in Regulatory Science, Carshalton, England